Fusobacterium is toxic for head and neck squamous cell carcinoma and its presence may determine a better prognosis.

Autor: Chander A; Centre for Host-Microbiome Interactions, King's College London, London, UK.; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK., Iacovacci J; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pellon A; Centre for Host-Microbiome Interactions, King's College London, London, UK., Kataria R; Comprehensive Cancer Centre, King's College London, London, UK., Grigoriadis A; Comprehensive Cancer Centre, King's College London, London, UK., Maher J; Comprehensive Cancer Centre, King's College London, London, UK., Sears C; Medicine Department, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bachrach G; Institute of Biomedical and Oral Research, The Hebrew University-Hadassah School of Dental Medicine, Hadassah Ein Kerem Campus, Jerusalem, Israel., Urbano TG; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK., Lei M; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK., Petkar I; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK., Kong A; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK., Ng T; Comprehensive Cancer Centre, King's College London, London, UK., Orlandi E; Dipartimento di scienze Clinico-Chirurgiche, Diagnostiche e Pediatriche, Università degli studi di Pavia, Pavia, Italy., Iacovelli NA; Radiation Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Radiation Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Serafini MS; Radiation Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Medicine, Weill Cornell Medicine, New York, USA., Moyes D; Centre for Host-Microbiome Interactions, King's College London, London, UK., Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ferreira MR; Centre for Host-Microbiome Interactions, King's College London, London, UK.; Comprehensive Cancer Centre, King's College London, London, UK.; Department of Oncology, Guys and St Thomas NHS Foundation Trust, London, UK.

Publikováno v: Cancer communications (London, England) [Cancer Commun (Lond)] 2024 Aug; Vol. 44 (8), pp. 879-883. Date of Electronic Publication: 2024 Jul 06.

Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk

Autor: Dean, J.A. ^∗, Welsh, L.C. ^†, Wong, K.H. ^†, Aleksic, A. ^†, Dunne, E. ^†, Islam, M.R. ^†, Patel, A. ^†, Patel, P. ^†, Petkar, I. ^†, Phillips, I. ^†, Sham, J. ^†, Schick, U. ^†, Newbold, K.L. ^{†, ‡}, Bhide, S.A. ^{†, ‡}, Harrington, K.J. ^{†, ‡}, Nutting, C.M. ^{†, ‡}, Gulliford, S.L. ^∗

Publikováno v: In Clinical Oncology April 2017 29(4):263-273

Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer - Authors' reply.

Autor: Nutting C; Head and Neck Unit, The Royal Marsden Hospital, London, UK; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK. Electronic address: chris.nutting@rmh.nhs.uk., Finneran L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Roe J; Department of Speech, Voice and Swallowing, The Royal Marsden Hospital, London, UK; Department of Surgery and Cancer, Imperial College, London, UK., Petkar I; Department of Oncology, Guys and St Thomas' Hospital, London, UK., Rooney K; Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, UK., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Oct; Vol. 24 (10), pp. e398.

Protocol letter: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study (InGReS) - A Phase 1 multicentre feasibility study.

Autor: Adjogatse D; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: Delali.adjogatse@gstt.nhs.uk., Michaelidou A; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Sanchez Nieto B; Institute of Physics, Pontificia Universidad Catolica de Chile, Santiago, Chile., Kozarski R; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Sassoon I; Computer Science Department, Brunel University London, Uxbridge, UK., Evans M; Department of Oncology, Velindre University NHS Trust, Cardiff, UK., Rackley T; Department of Oncology, Velindre University NHS Trust, Cardiff, UK., Shah S; Department of Medical Physics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Eaton D; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Department of Medical Physics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Pike L; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Curry S; King's College and Guy's and St Thomas' Hospital PET Centre, London, UK., Gould SM; King's College and Guy's and St Thomas' Hospital PET Centre, London, UK., Thomas C; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Department of Medical Physics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kong A; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Petkar I; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Reis-Ferreira M; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Connor S; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; Department of Radiology Guy's and St Thomas' NHS Foundation Trust, London, UK; Department of Neuroradiology, King's College Hospital, London UK., Barrington SF; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK; King's College and Guy's and St Thomas' Hospital PET Centre, London, UK., Lei M; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Guerrero Urbano T; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK; King's College London, Faculty of Dentistry, Oral and Craniofacial Sciences, London, UK.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Jun; Vol. 183, pp. 109645. Date of Electronic Publication: 2023 Mar 28.

Clinical outcomes in relapsed oropharyngeal cancer after definitive (chemo) radiotherapy.

Autor: De Felice F; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK.; Department of Radiotherapy, Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Bird T; Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK., Michaelidou A; King's College London, London, UK.; Kent Oncology Centre, London, UK., Jeannon JP; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Simo R; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Oakley R; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Lyons A; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Fry A; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Cascarini L; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Asit A; Department of Otorhinolaryngology Head and Neck Surgery, Guys and St Thomas' NHS Trust, Great Maze Pond, London, UK., Thavaraj S; Department of Head and Neck Pathology, Guy's and St Thomas' NHS Trust, London, UK.; Centre for Oral, Clinical and Translational Science, King's College London, London, UK., Reis Ferreira M; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK., Petkar I; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK., Kong A; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK., Lei M; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK., Guerrero Urbano T; Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK.

Publikováno v: Oral diseases [Oral Dis] 2023 Mar; Vol. 29 (2), pp. 595-603. Date of Electronic Publication: 2021 Aug 27.